Jiajie Yu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Prognostic Factors

Patient Reported Outcomes

Top Venues

Cancer chemotherapy and pharmacology

Drug metabolism and disposition: the biological fate of chemicals

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Vikram Malhi, Malgorzata Nowicka, Ya-Chi Chen, Priya Agarwal, Marie Waldvogel, Yi Ting Kayla Lien, Marc Hafner, Pablo Perez-Moreno, Heather M Moore, Jiajie Yu
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure. Cancer chemotherapy and pharmacology 94 (1) (2024)
Vikram Malhi, Malgorzata Nowicka, Ya-Chi Chen, Priya Agarwal, Marie Waldvogel, Yi Ting Kayla Lien, Marc Hafner, Pablo Perez-Moreno, Heather M Moore, Jiajie Yu
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure. Cancer chemotherapy and pharmacology 94 (1) (2024)
Vikram Malhi, Malgorzata Nowicka, Ya-Chi Chen, Priya Agarwal, Marie Waldvogel, Yi Ting Kayla Lien, Marc Hafner, Pablo Perez-Moreno, Heather M Moore, Jiajie Yu
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure. Cancer chemotherapy and pharmacology (2024)
Vikram Malhi, Malgorzata Nowicka, Ya-Chi Chen, Priya Agarwal, Marie Waldvogel, Yi Ting Kayla Lien, Marc Hafner, Pablo Perez-Moreno, Heather M Moore, Jiajie Yu
UGT1A4 Polymorphism is not Associated with a Clinically Relevant Change in Giredestrant Exposure. Cancer chemotherapy and pharmacology 94 (1) (2024)
Smita Kshirsagar, Ya-Chi Chen, Jiajie Yu, Mary R Gates, Sonoko Kawakatsu, S Cyrus Khojasteh, Shuguang Ma, Luna Musib, Vikram Malhi, Uyi Osaghae, Jing Wang, Sungjoon Cho, Yang Tang, Donglu Zhang, Weiping Zhao, Tom De Bruyn
Mass Balance, Metabolic Pathways, Absolute Bioavailability, And Pharmacokinetics of Giredestrant In Healthy Subjects. Drug metabolism and disposition: the biological fate of chemicals (2024)
Smita Kshirsagar, Ya-Chi Chen, Jiajie Yu, Mary R Gates, Sonoko Kawakatsu, S Cyrus Khojasteh, Shuguang Ma, Luna Musib, Vikram Malhi, Uyi Osaghae, Jing Wang, Sungjoon Cho, Yang Thomas Tang, Donglu Zhang, Weiping Zhao, Tom De Bruyn
Mass Balance, Metabolic Pathways, Absolute Bioavailability, and Pharmacokinetics of Giredestrant in Healthy Subjects. Drug metabolism and disposition: the biological fate of chemicals 52 (8) (2024)
Komal L Jhaveri, Meritxell Bellet-Ezquerra, Nicholas C Turner, Sherene Loi, Aditya Bardia, Valentina Boni, Joo Hyuk Sohn, Tomas G Neilan, Rafael Villanueva-Vázquez, Peter Kabos, Laura García Estévez, Elena Lopez-Miranda, José Alejandro Pérez-Fidalgo, Jose Manuel Perez-Garcia, Jiajie Yu, Jill Fredrickson, Heather M Moore, Ching-Wei Chang, John W Bond, Jennifer Eng-Wong, Mary R Gates, Elgene Lim
Phase Ia/b Study of Giredestrant ±Palbociclib and ±Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vikram Malhi, Priya Agarwal, Mary R Gates, Lichuan Liu, Jianshuang Wang, Tom De Bruyn, Scott Lam, Jennifer Eng-Wong, Pablo Perez-Moreno, Ya-Chi Chen, Jiajie Yu
Optimizing Early-Stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast Cancer. Cancer research communications (2023)